Search
for
Sort by
Research 151–180 of 790
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The role of janus kinases in the treatment of autoimmune skin diseases
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Poster Presentations
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Baricitinib for the Treatment of Alopecia Areata
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Baricitinib as a treatment for myasthenia gravis: A case report
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Janus kinase inhibitors for alopecia areata: A narrative review